Six of our own production sites are located in Finland, one in France, and one in Belgium. Orion has in-house sales operations in 27 European countries and in six countries in the Asia-Pacific region.
Orion around the world
Where we are
Orion has more than 3,500 employees around the world. Our products are sold in over one hundred countries.
Orion in Finland
- Orion's head office and largest campus
- Approx. 1,500 Orionees work in Espoo
- Tablet, injection, and inhalation product manufacturing
- Research & Development, production, technology, procurement, sales and marketing, registration, administration, and other functions
- Approx. 700 Orionees work in Turku
- Research & Development, production, technology, procurement, sales and marketing, registration
- The Turku plant produces tablets, cytostatic cancer drugs, all of Orion's basic creams, and other products
- Approx. 170 Orionees work in Salo
- Centralised tablet packaging facility with seven production lines
- Central warehouse from which nearly all Orion products are distributed
- Active pharmaceutical ingredient (API) manufacturing plant
- Approx. 170 employees work in Hanko
- Four factory units, including post-processing
- The Hanko plant manufactures pharmaceutical ingredients with annual volumes of thousands of kilograms
- Entacapone, which is used in the treatment of Parkinson's disease, is one of the APIs manufactured in Hanko
- Active pharmaceutical ingredient (API) manufacturing plant
- Approx. 100 employees work in Oulu
- Ten production modules and post-processing
- Manufacture of highly potent APIs with relatively small annual volumes yet demanding and long manufacturing processes
- Methotrexate, which is used in the treatment of arthritis and cancer, is one of the APIs manufactured in Oulu
- Over 40 Orionees work in Kuopio
- The Kuopio plant manufactures especially cough medicines, nasal sprays, ear products, solutions, and drops
